Baldini Chiara, Delle Sedie Andrea, Luciano Nicoletta, Pepe Pasquale, Ferro Francesco, Talarico Rosaria, Tani Chiara, Mosca Marta
Rheumatology Unit, University of Pisa, Via Roma, 67, 56126, Pisa, Italy,
Rheumatol Int. 2014 Aug;34(8):1159-64. doi: 10.1007/s00296-013-2872-3. Epub 2013 Oct 6.
Beyond its well-established role in the maintenance of mineral homeostasis, 25-OH-vitamin D deficiency seems to be involved in the development and severity of several autoimmune diseases. To date, contrasting data have been reported regarding the presence of hypovitaminosis D in primary Sjögren's syndrome (pSS). To assess the prevalence of hypovitaminosis D in pSS at an early stage of the disease and to evaluate its impact on pSS clinical manifestations and disease activity, unselected consecutive subjects with recent onset dry mouth and/or dry eyes who underwent a comprehensive diagnostic algorithm for pSS (AECG criteria) were prospectively included in the study. The levels of 25[OH]-D3 were measured by monoclonal antibody immunoradiometric assay. Conditions of 25[OH]-D3 severe deficiency, deficiency, and insufficiency were defined as levels <10, <20, and 20-30 ng/ml, respectively, and their frequencies were investigated in pSS patients and controls. The levels of 25[OH]-D3 were also correlated with patients' demographic, clinical, and serologic features. Seventy-six consecutive females were included: 30/76 patients fulfilled the AECG criteria for pSS. The remaining 46/76 patients represented the control group. No statistical differences were found in the serum levels of 25[OH]-D3 between pSS patients [median levels = 20 ng/ml (IQR 9.3-26)] and controls [median levels = 22.5 ng/ml (IQR 15.6-33)]. In particular, the frequency of 25[OH]-D3 severe deficiency was not significantly different in patients with pSS when compared to controls (23 vs. 17.4 %, p value = 0.24). We found a significant correlation between serum 25[OH]-D3 levels and white blood cells count (r = 0.29, p = 0.01). More specifically, leukocytopenia was significantly associated with 25[OH]-D3 severe deficiency, being documented in 40 % of the subjects with a 25[OH]-D3 severe deficiency and in 11 % of the subjects without a severe vitamin D deficiency (p = 0.02). We did not observe any further association or correlation between hypovitaminosis D and pSS glandular and extra-glandular features. Although the role of hypovitaminosis D in pSS pathogenesis remains controversial, the results of this study encourage the assessment of vitamin D in specific pSS subsets that could mostly benefit from a supplementation.
除了在维持矿物质稳态方面已确立的作用外,25-羟基维生素D缺乏似乎还与几种自身免疫性疾病的发生和严重程度有关。迄今为止,关于原发性干燥综合征(pSS)中维生素D缺乏症的存在,已有相互矛盾的数据报道。为了评估疾病早期pSS中维生素D缺乏症的患病率,并评估其对pSS临床表现和疾病活动的影响,本研究前瞻性纳入了未经选择的、近期出现口干和/或眼干且接受了pSS综合诊断算法(AECG标准)的连续受试者。通过单克隆抗体免疫放射分析测定25[OH]-D3水平。25[OH]-D3严重缺乏、缺乏和不足的情况分别定义为水平<10、<20和20 - 30 ng/ml,并在pSS患者和对照组中调查其频率。25[OH]-D3水平还与患者的人口统计学、临床和血清学特征相关。纳入了76名连续的女性:30/76例患者符合pSS的AECG标准。其余46/76例患者为对照组。pSS患者[中位数水平 = 20 ng/ml(四分位间距9.3 - 26)]和对照组[中位数水平 = 22.5 ng/ml(四分位间距15.6 - 33)]的血清25[OH]-D3水平无统计学差异。特别是,pSS患者中25[OH]-D3严重缺乏的频率与对照组相比无显著差异(23%对17.4%,p值 = 0.24)。我们发现血清25[OH]-D3水平与白细胞计数之间存在显著相关性(r = 0.29,p = 0.01)。更具体地说,白细胞减少与25[OH]-D3严重缺乏显著相关,在25[OH]-D3严重缺乏的受试者中有40%记录到白细胞减少,而在无严重维生素D缺乏的受试者中有11%记录到白细胞减少(p = 0.02)。我们未观察到维生素D缺乏与pSS的腺体和腺外特征之间有任何进一步的关联或相关性。尽管维生素D缺乏在pSS发病机制中的作用仍存在争议,但本研究结果鼓励在可能最受益于补充剂的特定pSS亚组中评估维生素D。